首页> 外文期刊>Drug development and industrial pharmacy >Enhanced oral bioavailability of Wurenchun (Fructus Schisandrae Chinensis extracts) by self-emulsifying drug delivery systems.
【24h】

Enhanced oral bioavailability of Wurenchun (Fructus Schisandrae Chinensis extracts) by self-emulsifying drug delivery systems.

机译:通过自乳化药物递送系统提高五人春(五味子提取物)的口服生物利用度。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Wurenchun is the alcohol extract from Fructus Schisandrae Chinensis, which has good efficiency in lowering abnormal serum glutamic pyruvic transaminase (SGPT) level of patients suffering from acute or chronic hepatitis. The main purpose of this work is to prepare self-emulsifying drug delivery systems (SEDDS) for enhancing the solubility, dissolution rate, and oral bioavailability of poorly water-soluble traditional Chinese medicines, Wurenchun. METHODS: Pseudoternary phase diagrams were used to evaluate the efficient self-emulsification domains, and particle size distributions of resultant emulsions were determined. The dissolution test was performed according to the second method of Chinese Pharmacopoeia dissolution procedure. The pharmacokinetic study in rats for the optimized formulation was performed and compared to commercial capsules. RESULTS: The optimized formulation for bioavailability assessment consisted of 20% oleic acid, 65% Tween 20, and 15% Transcutol P. The mean droplet size distribution of the optimized SEDDS was approximately 240 nm when diluted with 1000-fold volume of the distilled water. The in vitro dissolution rates of the active components of Wurenchun SEDDS were significantly higher than those of the commercial capsules. SEDDS have significantly increased the C(max) and area under the curve) (AUC) of Wurenchun compared to reference capsules (P < 0.05). And the relative bioavailability of SEDDS for schisandrin and schisandrin B was 292.2% and 205.8% compared to the commercial capsules, respectively. CONCLUSION: The results suggest the potential use of SEDDS to improve oral absorption of the sparingly soluble drugs or traditional Chinese medicine, such as Wurenchun.
机译:背景:五仁春是五味子的乙醇提取物,对降低急性或慢性肝炎患者的血清谷氨酸丙酮酸转氨酶(SGPT)水平具有良好的效果。这项工作的主要目的是制备自乳化药物递送系统(SEDDS),以提高水溶性较差的中药乌仁春的溶解度,溶出度和口服生物利用度。方法:使用伪三元相图评估有效的自乳化域,并确定所得乳液的粒径分布。溶出度试验按照中国药典溶出度测定法的第二种方法进行。在大鼠中进行了优化配方的药代动力学研究,并将其与市售胶囊进行了比较。结果:用于生物利用度评估的优化配方由20%的油酸,65%的Tween 20和15%的Transcutol P组成。当以1000倍体积的蒸馏水稀释时,优化的SEDDS的平均液滴尺寸分布约为240 nm。 。 ren仁春SEDDS活性成分的体外溶出度明显高于市售胶囊。与参考胶囊相比,SEDDS显着增加了五人春的C(max)和曲线下面积(AUC)(P <0.05)。与市售胶囊相比,五味子素和五味子素B的SEDDS相对生物利用度分别为292.2%和205.8%。结论:结果表明,SEDDS可能用于改善微溶性药物或中药如五人春的口服吸收。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号